Our data support previously published results suggesting that hepatic nuclear receptors modulating genes controlling fatty acid and bile acid metabolism, including liver nuclear receptors PPARs, CAR, PXR and FXR, are inactivated in NASH patients [21,22,23,24]. This evidence concerns the gene NR1I2 and metabolic dysfunction-associated steatohepatitis.